Celemics, Inc.

Celemics, Inc.

생명공학 연구

Geumcheon-gu Seoul 팔로워 2,390명

NGS Panel Design&Bioinformatics - In-house Development of Reagent - NGS Assay Development Capability for New Application

소개

Celemics is a Next Generation Sequencing (NGS) full solution provider based on target enrichment technology. We confidently offer custom target enrichment panels and high-quality pre-set panels, covering fields such as Inherited Diseases, Oncology, Immunology, and Pathogen Diagnostics. With 13 years of experience, we will provide the best solution for your Targeted Sequencing. [Products/Services] OncoRisk (Hereditary Cancer) | CancerScreen (Somatic Cancer) | Custom Target Enrichment Panel | Whole Exome Sequencing | Clinical Exome Sequencing | BRCA 1/2 | PharmacoScreen | Comprehensive Respiratory Virus | Agrigenomics

업계
생명공학 연구
회사 규모
직원 51-200명
본사
Geumcheon-gu Seoul
유형
상장기업
설립
2010
전문 분야
NGS, Target Sequencing, Whole Exome Panel, Somatic Cancer Panel, Clinical Exome Panel, Customized NGS Panel, Target Enrichment Panel, NGS panel, Bioinformatics, Bioinformatics Analysis, Agrigenomics, Liquid Biopsy, Cancer research, Oncology Diagnositcs, Inherited Diseases, Virus Research, NGS Target Enrichment Panel, NGS reagents, NGS Probe design 및 clinical NGS

위치

  • 기본

    19-20F, BYC Highcity Bldg. A

    Gasandigital 1-ro 131

    KR Geumcheon-gu Seoul 08506

    길 보기

Celemics, Inc. 직원

업데이트

비슷한 페이지

자금조달

Celemics, Inc. 총 1라운드

마지막 라운드

시리즈 알수없음
크런치베이스에서 자세히 알아보기